An editorial in this week’s issue highlights the enhancement in compounding regulations over the last few years and the valuable role that FIRST Compounding Kits play to help facilitate compliance with the updated regulations governing compounding. Read More Back to...
Robert M. Palladino named as Chief Financial Officer, Dr. Yatindra Joshi as Special Advisor to the Board of Directors to accelerate Strategic Growth Plan activities. WILMINGTON, Mass. (August 1, 2017) – CutisPharma today announced the appointments of Robert M....
Recent Comments